Literature DB >> 27287605

Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.

S Anjum1, A D Muzaale1, A B Massie1,2, S Bae1, X Luo1, M E Grams2,3, K L Lentine4, A X Garg5, D L Segev1,2.   

Abstract

Inferences about late risk of end-stage renal disease (ESRD) in live kidney donors have been extrapolated from studies averaging <10 years of follow-up. Because early (<10 years) and late (≥10 years) postdonation ESRD may differ by causal mechanism, it is possible that extrapolations are misleading. To better understand postdonation ESRD, we studied patterns of common etiologies including diabetes, hypertension and glomerulonephritis (GN; as reported by providers) using donor registry data linked to ESRD registry data. Overall, 125 427 donors were observed for a median of 11.0 years (interquartile range 5.3-15.7 years; maximum 25 years). The cumulative incidence of ESRD increased from 10 events per 10 000 at 10 years after donation to 85 events per 10 000 at 25 years after donation (late vs. early ESRD, adjusted for age, race and sex: incidence rate ratio [IRR] 1.3 1.72.3 [subscripts are 95% confidence intervals]). Early postdonation ESRD was predominantly reported as GN-ESRD; however, late postdonation ESRD was more frequently reported as diabetic ESRD and hypertensive ESRD (IRR 2.3 7.725.2 and 1.4 2.64.6 , respectively). These time-dependent patterns were not seen with GN-ESRD (IRR 0.4 0.71.2 ). Because ESRD in live kidney donors has traditionally been reported in studies averaging <10 years of follow-up, our findings suggest caution in extrapolating such results over much longer intervals. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; donors and donation: donor follow-up; donors and donation: living; kidney transplantation/nephrology

Mesh:

Year:  2016        PMID: 27287605      PMCID: PMC6116527          DOI: 10.1111/ajt.13917

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  39 in total

1.  The Risks of Living Kidney Donation.

Authors:  Robert W Steiner
Journal:  N Engl J Med       Date:  2015-11-06       Impact factor: 91.245

2.  Analytical methods and database design: implications for transplant researchers, 2005.

Authors:  G N Levine; K P McCullough; A M Rodgers; D M Dickinson; V B Ashby; D E Schaubel
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

3.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

4.  Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.

Authors:  C Y Hsu
Journal:  J Hum Hypertens       Date:  2001-02       Impact factor: 3.012

5.  Evaluation of living renal donors. The current practice of US transplant centers.

Authors:  M J Bia; E L Ramos; G M Danovitch; R S Gaston; W E Harmon; A B Leichtman; P A Lundin; J Neylan; B L Kasiske
Journal:  Transplantation       Date:  1995-08-27       Impact factor: 4.939

Review 6.  Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.

Authors:  Rafael Marín; Manuel Gorostidi; Francisco Fernández-Vega; Rafael Alvarez-Navascués
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

7.  A prospective controlled study of living kidney donors: three-year follow-up.

Authors:  Bertram L Kasiske; Teresa Anderson-Haag; Ajay K Israni; Roberto S Kalil; Paul L Kimmel; Edward S Kraus; Rajiv Kumar; Andrew A Posselt; Todd E Pesavento; Hamid Rabb; Michael W Steffes; Jon J Snyder; Matthew R Weir
Journal:  Am J Kidney Dis       Date:  2015-03-17       Impact factor: 8.860

8.  Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Authors:  Morgan E Grams; Yingying Sang; Andrew S Levey; Kunihiro Matsushita; Shoshana Ballew; Alex R Chang; Eric K H Chow; Bertram L Kasiske; Csaba P Kovesdy; Girish N Nadkarni; Varda Shalev; Dorry L Segev; Josef Coresh; Krista L Lentine; Amit X Garg
Journal:  N Engl J Med       Date:  2015-11-06       Impact factor: 91.245

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Estimating the long term impact of kidney donation on life expectancy and end stage renal disease.

Authors:  Bryce A Kiberd
Journal:  Transplant Res       Date:  2013-02-16
View more
  27 in total

1.  Risk of ESKD in Older Live Kidney Donors with Hypertension.

Authors:  Fawaz Al Ammary; Xun Luo; Abimereki D Muzaale; Allan B Massie; Deidra C Crews; Madeleine M Waldram; Mohamud A Qadi; Jacqueline Garonzik-Wang; Macey L Henderson; Daniel C Brennan; Alexander C Wiseman; Richard C Lindrooth; Jon J Snyder; Josef Coresh; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 8.237

2.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Authors:  Krista L Lentine; Farrukh M Koraishy; Nagaraju Sarabu; Abhijit S Naik; Ngan N Lam; Amit X Garg; David Axelrod; Zidong Zhang; Gregory P Hess; Bertram L Kasiske; Dorry L Segev; Macey L Henderson; Allan B Massie; Courtenay M Holscher; Mark A Schnitzler
Journal:  Clin Transplant       Date:  2019-09-08       Impact factor: 2.863

3.  Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

Authors:  Courtenay M Holscher; Christine E Haugen; Kyle R Jackson; Jacqueline M Garonzik Wang; Madeleine M Waldram; Sunjae Bae; Jayme E Locke; Rhiannon D Reed; Krista L Lentine; Gaurav Gupta; Matthew R Weir; John J Friedewald; Jennifer Verbesey; Matthew Cooper; Dorry L Segev; Allan B Massie
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-19       Impact factor: 8.237

4.  Transplantation: Long-term risk of ESRD in living donors.

Authors:  Andrea Aguilar
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

Review 5.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

Review 6.  Renal and cardiac assessment of living kidney donor candidates.

Authors:  Ngan N Lam; Krista L Lentine; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2017-04-03       Impact factor: 28.314

7.  A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.

Authors:  Arthur J Matas; Rebecca E Hays; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 8.237

8.  Hypertension after kidney donation: Incidence, predictors, and correlates.

Authors:  Otto A Sanchez; Laine K Ferrara; Sarah Rein; Danielle Berglund; Arthur J Matas; Hassan N Ibrahim
Journal:  Am J Transplant       Date:  2018-04-06       Impact factor: 8.086

9.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

10.  GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.

Authors:  Arthur J Matas; David M Vock; Hassan N Ibrahim
Journal:  Am J Transplant       Date:  2017-12-01       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.